DOW JONES28,992.41-227.57 -0.78%
S&P 5003,337.75-35.48 -1.05%
NASDAQ9,576.59-174.38 -1.79%

Mizuho Maintains Buy on Quest Diagnostics, Raises Price Target to $122

Mizuho analyst Ann Hynes maintains Quest Diagnostics (NYSE:DGX) with a Buy and raises the price target from $116 to $122.

Benzinga · 02/10/2020 12:59

Mizuho analyst Ann Hynes maintains Quest Diagnostics (NYSE:DGX) with a Buy and raises the price target from $116 to $122.